SCHEMBL8586756

SCHEMBL8586756

C[C@H](NC[C@H](O[Si](C)(C)C(C)(C)C)c1cccc(Cl)c1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 13/20 0.41
ADRB2 P07550 10/20 0.41
ADRB1 P08588 11/20 0.40
CYP2B6 P20813 1/20 0.40
ADRA1D P25100 2/20 0.39
ADRA1A P35348 2/20 0.39
ADRA1B P35368 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
SLC6A2 P23975 2/20 0.38
CHRNA1 P02708 1/20 0.38
CHRNG P07510 1/20 0.38
ITGA5 P08648 1/20 0.38
CHRNB1 P11230 1/20 0.38
CHRNB2 P17787 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8586761 1.00 ADRB3 (0.41) ADRB3ADRB2ADRB1CYP2B6ADRA1D
SCHEMBL7708901 0.90 SLC6A2 (0.39) ADRB3ADRB2ADRB1CYP2B6ADRA1D
SCHEMBL7069969 0.80 ADRB3 (0.35) ADRB3ADRB2ADRB1CYP2B6ADRA1D
SCHEMBL7714914 0.80 ADRB3 (0.40) ADRB3ADRB2ADRB1CYP2B6ADRA1D
SCHEMBL7714916 0.80 ADRB3 (0.40) ADRB3ADRB2ADRB1CYP2B6ADRA1D
SCHEMBL9063602 0.79 AOC3 (0.43) CYP2B6SLC6A2SLC6A4IDO1MEN1
SCHEMBL7708906 0.78 ADRB3 (0.39) ADRB3ADRB2ADRB1IDO1MEN1
SCHEMBL9274010 0.78 ADRB2 (0.46) ADRB3ADRB2ADRB1
SCHEMBL9274013 0.78 ADRB2 (0.46) ADRB3ADRB2ADRB1
SCHEMBL8310050 0.77 MEN1 (0.41) ADRB3ADRB2ADRB1CYP2B6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998043953-A1 NAPHTHALENESULPHONIC OR CARBOXYLIC ACIDS AND THEIR USE AS ATYPICAL BETA-ADRENOCEPTOR AGONISTS GLAXO GROUP LIMITED (GB) 1998-10-08 WO disclosed